These miRNAs effectively inhibited αvβ3 integrin-dependent FAK activation and restored sensitivity to the HSP90 inhibitor AUY922 in the KRAS-mutated NSCLC cell lines A549 and H1944 [137]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.